Genetic and Bioinformatic Strategies to Improve Diagnosis in Three Inherited Bleeding Disorders in Bogotá, Colombia

Juliana Lago1, Helena Groot1, Diego Navas1

  • 1Laboratorio de Genética Humana, Universidad de Los Andes, Bogotá 111711, Colombia.

Genes
|November 27, 2021
PubMed

Insights

This study identified novel genetic variations in inherited bleeding disorders like hemophilia A, hemophilia B, and von Willebrand Disease in Colombia. A low-cost, high-resolution melting technique with open-source analysis was validated for improved genetic diagnosis.

Area of Science:

  • Medical Genetics
  • Molecular Biology
  • Congenital Diseases

Background:

  • Inherited bleeding disorders (IBDs), including hemophilia A (HA), hemophilia B (HB), and von Willebrand Disease (VWD), are common congenital diseases in Colombia.
  • Current diagnostic methods rely on laboratory assays, but limited accessibility can lead to incomplete diagnoses, necessitating genetic confirmation.

Purpose of the Study:

  • To characterize the molecular genetic basis of IBDs in Colombian patients.
  • To validate the high-resolution melting (HRM) technique as a low-cost genetic diagnostic tool for IBDs.
  • To develop an open-source Python code for improved HRM data analysis.

Main Methods:

  • Sequencing of the F8, F9, and VWF genes in 11 HA, 3 HB, and 5 VWD patients.
  • Validation of the HRM variant-scanning technique using identified disease-causing variations.
  • Development and application of an open-source Python code for HRM data analysis, assessing sensitivity and bias.

Main Results:

  • Identified 12 variations in HA, 4 in HB, and 19 in VWD patients, with 25 novel variations discovered.
  • The HRM technique demonstrated high sensitivity (95%) and unbiased results across different equipment and software.
  • The developed Python code enhanced HRM data analysis, enabling analysis of amplicons over 300 bp.

Conclusions:

  • Genetic characterization revealed novel variations in Colombian IBD patients.
  • The validated HRM technique offers a cost-effective and sensitive method for genetic diagnosis of IBDs, suitable for developing countries.
  • The open-source analysis tool improves the accessibility and reliability of HRM-based genetic diagnostics.